{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:58:38Z","timestamp":1785466718445,"version":"3.56.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether the effect of late surfactant is modified by patent ductus arteriosus (PDA) status with respect to survival without bronchopulmonary dysplasia (BPD) in ventilated infants born &lt;28 weeks\u2019 gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Secondary analysis of the Trial of Late Surfactant (TOLSURF). A formal test of interaction between PDA presence and late surfactant, with respect to survival without BPD at 36 and 40 weeks\u2019 postmenstrual age (PMA), was performed. PDA presence was defined by PDA treatment, either medical or a ligation (definition A), or PDA ligation (definition B), during or after late surfactant administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All 511 infants were included. No interaction was detected between a PDA and late surfactant for survival without BPD at 36 weeks\u2019 PMA (definition A:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.41; definition B:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.33), or at 40 weeks\u2019 PMA (definition A:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.84; definition B:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.42).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PDA presence did not modify the effect of late surfactant for survival without BPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41372-026-02705-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:11:30Z","timestamp":1776697890000},"page":"1188-1193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect modification of late surfactant treatment by patent ductus arteriosus status in ventilated preterm infants: a secondary analysis of a randomized clinical trial"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-9456","authenticated-orcid":false,"given":"Patrick J.","family":"Peebles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens C.","family":"Eickhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Elgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anudeepa","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-093X","authenticated-orcid":false,"given":"Nicolas A.","family":"Bamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6693-1823","authenticated-orcid":false,"given":"Jonathan M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-8872","authenticated-orcid":false,"given":"Patrick J.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0743-8470","authenticated-orcid":false,"given":"Roberta L.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-6282","authenticated-orcid":false,"given":"Dinushan C.","family":"Kaluarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jama.2021.23580","volume":"327","author":"EF Bell","year":"2022","unstructured":"Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013\u20132018. JAMA. 2022;327:248\u201363.","journal-title":"JAMA"},{"key":"2705_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012. JAMA. 2015;314:1039\u201351.","journal-title":"JAMA"},{"key":"2705_CR3","doi-asserted-by":"publisher","first-page":"114456","DOI":"10.1016\/j.jpeds.2024.114456","volume":"279","author":"DC Kaluarachchi","year":"2024","unstructured":"Kaluarachchi DC, Rysavy MA, Do BT, Chock VY, Laughon MM, Backes CH, et al. Changes in patent ductus arteriosus management and outcomes in infants born at 26-28 weeks\u2019 gestation. J Pediatr. 2024;279:114456.","journal-title":"J Pediatr"},{"key":"2705_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpeds.2016.12.059","volume":"183","author":"RL Keller","year":"2017","unstructured":"Keller RL, Eichenwald EC, Hibbs AM, Rogers EE, Wai KC, Black DM, et al. The randomized, controlled trial of late surfactant: effects on respiratory outcomes at 1-year corrected age. J Pediatr. 2017;183:19\u201325.e2.","journal-title":"J Pediatr"},{"key":"2705_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamapediatrics.2015.4617","volume":"170","author":"JM Hascoet","year":"2016","unstructured":"Hascoet JM, Picaud JC, Ligi I, Blanc T, Moreau F, Pinturier MF, et al. Late surfactant administration in very preterm neonates with prolonged respiratory distress and pulmonary outcome at 1 year of age: a randomized clinical trial. JAMA Pediatr. 2016;170:365\u201372.","journal-title":"JAMA Pediatr"},{"key":"2705_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2015.09.031","volume":"168","author":"RA Ballard","year":"2016","unstructured":"Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, et al. Randomized trial of late surfactant treatment in ventilated preterm infants receiving inhaled nitric oxide. J Pediatr. 2016;168:23\u20139.e4.","journal-title":"J Pediatr"},{"key":"2705_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1542\/peds.2007-2680","volume":"123","author":"M Laughon","year":"2009","unstructured":"Laughon M, Bose C, Moya F, Aschner J, Donn SM, Morabito C, et al. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia. Pediatrics. 2009;123:89\u201396.","journal-title":"Pediatrics"},{"key":"2705_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/pr.2012.136","volume":"72","author":"RL Keller","year":"2012","unstructured":"Keller RL, Merrill JD, Black DM, Steinhorn RH, Eichenwald EC, Durand DJ, et al. Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study. Pediatr Res. 2012;72:613\u20139.","journal-title":"Pediatr Res"},{"key":"2705_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.jp.7211533","volume":"26","author":"LA Katz","year":"2006","unstructured":"Katz LA, Klein JM. Repeat surfactant therapy for postsurfactant slump. J Perinatol. 2006;26:414\u201322.","journal-title":"J Perinatol"},{"key":"2705_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/archdischild-2023-326333","volume":"109","author":"G Solis-Garcia","year":"2024","unstructured":"Solis-Garcia G, Elias S, Dunn M, Jasani B. Late surfactant administration after 48\u2009hours of age in preterm neonates with respiratory insufficiency: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2024;109:301\u20137.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2705_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41372-023-01689-2","volume":"43","author":"MS Beauchene","year":"2023","unstructured":"Beauchene MS, Cunningham AM, Stanford AH, Bischoff AR, Dagle JM, Rios DR, et al. Patent ductus arteriosus (PDA) and response to late surfactant treatment in premature infants. J Perinatol. 2023;43:1245\u201351.","journal-title":"J Perinatol"},{"key":"2705_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. Am J Respir Crit Care Med. 2019;200:751\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2705_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJMoa2207418","volume":"388","author":"T Hundscheid","year":"2023","unstructured":"Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, de Vries WB, Dijkman KP, et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N Engl J Med. 2023;388:980\u201390.","journal-title":"N Engl J Med"},{"key":"2705_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/jp.2010.3","volume":"30","author":"WE Benitz","year":"2010","unstructured":"Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30:241\u201352.","journal-title":"J Perinatol"},{"key":"2705_CR15","doi-asserted-by":"crossref","unstructured":"Ambalavanan N, Aucott SW, Salavitabar A, et al; American Academy of Pediatrics, Committee on Fetus and Newborn and Section on Cardiology and Cardiac Surgery. Patent Ductus Arteriosus in Preterm Infants. Pediatrics. 2025;155:e2025071425.","DOI":"10.1542\/peds.2025-071425"},{"key":"2705_CR16","first-page":"CD013278","volume":"6","author":"S Mitra","year":"2025","unstructured":"Mitra S, Scrivens A, Fiander M, Disher T, Weisz DE. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Cochrane Database Syst Rev. 2025;6:CD013278.","journal-title":"Cochrane Database Syst Rev"},{"key":"2705_CR17","doi-asserted-by":"crossref","unstructured":"Buvaneswarran S, Wong YL, Liang S, Quek SC, Lee J. Active treatment vs expectant management of patent ductus arteriosus in preterm infants: a meta-analysis. JAMA Pediatr. 2025;179:877\u201385.","DOI":"10.1001\/jamapediatrics.2025.1025"},{"key":"2705_CR18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2024.17380","volume":"332","author":"BJ Manley","year":"2024","unstructured":"Manley BJ, Kamlin COF, Donath SM, Francis KL, Cheong JLY, Dargaville PA, et al. Intratracheal budesonide mixed with surfactant for extremely preterm infants: the PLUSS randomized clinical trial. JAMA. 2024;332:1889\u201399.","journal-title":"JAMA"},{"key":"2705_CR19","unstructured":"Sekulich D. Relaxatory effects of commercial surfactants on ductus arteriosus tone reveals an underlying mechanism for surfactant-associated PDA. Pediatric Academic Societies Annual Meeting. 2024."}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02705-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:03:47Z","timestamp":1785463427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02705-x","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}